Reported Feb 22, 2017 · Terminated

Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo…

Aurobindo Pharma USA Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Aurobindo Pharma USA Inc · 666 Plainsboro Rd Ste 210 · Plainsboro, NJ · 08536-3004

Is this the product you have?

  • Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only
  • Manufactured forAurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton
  • NJ 08810 Manufactured byAurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30
Lot codes and dates
    • Lot #: VI3716010-A
    • Exp. 04/2018
Amount recalled
47,040 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Aurobindo Pharma USA Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 19, 2019 · Data as of Sep 19, 4:17 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.